References
Garotta F, Messa A. Safety profile of ceftizoxime: an Italian experience in 14,007 patients. Journal of Chemotherapy 3 (Suppl. 2): 36–38, 1991
Garotta F, Umile A. Post-marketing surveillance with ceftizoxime in 5081 elderly patients. Journal of Chemotherapy 1 (Suppl. 4): 666–668, 1989
Garotta F, Umile A, Pamparana F, Montoro C, Meinardi G. Phase IV clinical trials with ceftizoxime (Eposerin®) in 3201 patients in Italy. A post-marketing surveillance report. Clinical Trials Journal 26: 201–215, 1989
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zottino, G., Garotta, F. & Messa, A. Safety Profile of Ceftizoxime. Drug Invest 4 (Suppl 1), 48–49 (1992). https://doi.org/10.1007/BF03258349
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03258349